Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?

Journal of Natural Products

Volumn 76, Issue 6, 2013, Pages 1105-1112

  Minassi, Alberto ^a   Sánchez Duffhues, Gonzalo ^b   Collado, Juan Antonio ^b   Muñoz, Eduardo ^b   Appendino, Giovanni ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NATURAL PRODUCT; THIOL; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BIOLOGICAL ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROGENATION; PHARMACOPHORE; PHENOTYPE; PRENYLATION; TRANSACTIVATION;

CURCUMIN; HIV-1; MOLECULAR STRUCTURE; NF-KAPPA B; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS 1; THIA;

EID: 84879675979     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np400148e     Document Type: Article

References (34)

1. Goel, A.; Kunnumakkara, A. J.; Aggarwal, B. B. Biochem. Pharmacol. 2008, 75, 787-809
2. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Mol. Pharmacol. 2007, 4, 807-818
3. Aggarwal, B. B.; Sung, B. Trends Pharmacol. Sci. 2009, 30, 85-94
4. Zhou, H.; Beevers, C. S.; Huang, S. Curr. Drug Targets 2011, 12, 332-347
5. Gupta, S. C.; Prasad, S.; Kim, J. H.; Patchva, S.; Webb, L. J.; Priyadarsini, I. K.; Aggarwal, B. B. Nat. Prod. Rep. 2011, 28, 1937-1955
6. Zhang, H. S.; Ruan, Z.; Sang, W. W. J. Cell. Physiol. 2011, 226, 3385-3391
7. Preetha, A.; Thomas, S. G.; Kunnumakkara, A. B.; Sundaram, C.; Harikumar, K. B.; Sung, B.; Tharakan, S. T.; Misra, K.; Priyadarsini, I. K.; Rajasekharan, K. N.; Aggarwal, B. B. Biochem. Pharmacol. 2008, 76, 1590-1611
8. Lv, H.; She, G. Nat. Prod. Commun. 2010, 5, 1687-1708
9. Minassi, A.; Giana, A.; Ech-Chahad, A.; Appendino, G. A. Org. Lett. 2008, 10, 2267-2270 and references therein
10. Marcu, M. G.; Jung, Y. J.; Lee, S.; Chung, E. J.; Lee, M. J.; Trepel, J.; Neckers, L. Med. Chem. 2006, 2, 169-174
11. Wahlang, B.; Pawar, Y. B.; Bansal, A. K. Eur. J. Pharm. Biopharm. 2011, 77, 275-281
12. Ferrari, E.; Pignedoli, F.; Imbriano, C.; Marverti, G.; Basile, V.; Venturi, E.; Saladini, M. J. Med. Chem. 2011, 54, 8066-8077
13. Nicolaou, K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G.-Q.; Barluenga, S.; Mitchell, H. J. J. Am. Chem. Soc. 2000, 122, 9939-9953
14. Nicolaou, K. C.; Pfefferkorn, J. A.; Mitchell, H. J.; Roecker, A. J.; Barluenga, S.; Cao, G.-Q.; Affleck, R. L.; Lillig, J. E. J. Am. Chem. Soc. 2000, 122, 9954-9967
15. Pabon, H. J. Rec. Trav. Chim. 1964, 83, 379-386
16. Appendino, G.; Cravotto, G.; Palmisano, G.; Annunziata, R.; Szallasi, A. J. Med. Chem. 1996, 39, 3123-3131
17. Avonto, C.; Taglialatela-Scafati, O.; Pollastro, F.; Minassi, A.; Di Marzo, V.; De Petrocellis, L.; Appendino, G. Angew. Chem., Int. Ed. 2011, 50, 467-471
18. Márquez, N.; Sancho, R.; Macho, A.; Moure, A.; Masip, I.; Messeguer, A.; Muñoz, E. Biochem. Pharmacol. 2006, 71, 596-604
19. Sánchez-Duffhues, G.; Calzado, M. A.; de Vinuesa, A. G.; Appendino, G.; Fiebich, B. L.; Loock, U.; Lefarth-Risse, A.; Krohn, K.; Muñoz, E. Biochem. Pharmacol. 2009, 77, 1401-1409
20. Jungand, K. A.; Kwak, M. K. Molecules 2010, 15, 7266-7291
21. Demirovic, D.; Rattan, S. I. Biogerontology 2011, 12, 437-44
22. Biringer, M. Pharm. Res. 2011, 28, 2680-2694
23. Schmitz, M. L.; Mattioli, I.; Buss, H.; Kracht, M. ChemBioChem 2004, 5, 1348-1358
24. Karin, M.; Ben-Neriah, Y. Annu. Rev. Immunol. 2000, 18, 621-663
25. A previous study reporting only marginal, if any, activity of hydrogenated curcuminoids as NF-κB inhibitors was based on an indirect evaluation of this action and seems to have underestimated the activity of these compounds. Sandur, S. K.; Pandey, M. K.; Sung, B.; Ahn, K. S.; Murakami, A.; Sethi, G. Carcinogenesis 2007, 28, 1765-1773
26. Chen, Y. R.; Tan, T. H. Oncogene 1998, 17, 173-178
27. Johri, M. K.; Mishra, R.; Chhatbar, C.; Unni, S. K.; Singh, S. K. Expert Opin. Biol. Ther. 2011, 11, 269-283
28. Zhang, H. S.; Ruan, Z.; Sang, W. W. J. Cell Physiol. 2011, 226, 3385-3391
29. Mazumder, A.; Raghavan, K.; Weinstein, J.; Kohn, K. W.; Pommier, Y. Biochem. Pharmacol. 1995, 49, 1165-1170
30. The redundancy of targets and the lack of a consensus binding motif have even led to the suggestion that curcumin does not directly interact with many of its protein end-points, but rather inserts into lipid bilayers, modifying the energetic costs of their deformation and, indirectly, modulating the functioning of membrane-bound proteins. Barry, J.; Fritz, M.; Brender, J. R.; Smith, P. E. S.; Lee, D.-K.; Ramamoorthy, A. J. Am. Chem. Soc. 2009, 131, 4490-4499
31. Changtam, C.; de Koning, H. P.; Ibrahim, H.; Sajid, M. S.; Gould, M. K.; Suksamrarn, A. Eur. J. Med. Chem. 2010, 45, 4446-4457
32. Cuomo, J.; Appendino, G.; Adam, S.; Dern, A. S.; Schenier, E.; McKinnon, T. P.; Brown, M. J.; Togni, S.; Dixon, B. M. J. Nat. Prod. 2011, 74, 664-669
33. Babu, K. S.; Raju, B. C.; Praveen, B.; Kishore, K. H.; Murty, U. S.; Rao, J. M. Heterocycl. Commun. 2003, 9, 519-526
34. Sancho, R.; Márquez, N.; Gomez-Gonzalo, M.; Calzado, M. A.; Bettoni, G.; Coiras, M. T.; Alcami, J.; Lopez-Cabrera, M.; Appendino, G.; Muñoz, E. J. Biol. Chem. 2004, 279, 37349-37359